A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma

NCT04657991 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

257

Enrollment

INDUSTRY

Sponsor class

Conditions

Melanoma

Interventions

DRUG: Encorafenib
DRUG: Binimetinib
DRUG: Pembrolizumab

Sponsor

Pfizer

Collaborators

[object Object]